Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bone Solutions appoints CMO (chief medical officer):

This article was originally published in Clinica

Executive Summary

Dallas, Texas-based orthopaedic adhesive developer Bone Solutions has named Dr Stephen Schendel, professor and former head of Stanford University's plastic and reconstructive surgery department, chief medical officer. Bone Solutions is developing OsteoCrete for use as a bone filler and cement in orthopaedic and dental repair. The bioabsorbable magnesium-based compound incorporates the company's BioHesive technology and is said to be able to attach not only bone to bone, but also ligaments and tendons to bone.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT053556

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel